Monoclonal Antibodies Targeting CGRP: A Novel Treatment in Vestibular Migraine
<i>Background</i>. Monoclonal antibodies (mAbs) directed against the calcitonin gene-related peptide (CGRP) or its receptor represented the first targeted and specialized approach to migraine prophylaxis. Nevertheless, they have been rarely considered in the treatment of vestibular migraine (VM). Ou...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI AG
2023-08-01
|
| coleção: | Medicina |
| Assuntos: | |
| Acesso em linha: | https://www.mdpi.com/1648-9144/59/9/1560 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|